Literature DB >> 29283096

The Role of Topical Thymoquinone in the Treatment of Acute Otitis Externa; an Experimental Study in Rats.

Hasan Demirel1, Cengiz Arlı1, Tümay Özgür2, Melek İnci3, Recep Dokuyucu4.   

Abstract

OBJECTIVE: The aim of this experimental study was to compare the dose-related effect of topical thymoquinone (TQ) with other topical agents used in the management of acute otitis externa (AOE) in a rat model.
MATERIALS AND METHODS: Forty-eight male Wistar albino rats were divided into six groups each with eight rats per group. Group I was the control group with no external otitis, whereas external otitis were created in the other five groups (study groups). Dexamethasone, 0.1% TQ, 0.4% TQ, ciprofloxacin, and 0.9% saline (NaCl) drops was applied once daily in Groups II-VI, respectively. The treatment was administered regularly for 10 days. Pathologic and microbiologic evaluation were performed. Pathologically, the thicknesses of the stroma and the epithelium in the external auditory canal (EAC) were measured using an occulometer. Edema in the stroma, density of inflammatory cells and blood vessels, presence of fibroblasts, and changes in collagen fibers in the EAC were evaluated in five different areas to obtain the area of highest concentration and classified into four grades (0=no change, 1=mild, 2=moderate, 3=severe).
RESULTS: The higher concentration of TQ (0.4%) was more effective than dexamethasone and 0.1% TQ with respect to antibacterial and the anti-inflammatory properties.
CONCLUSION: TQ, particularly at a concentration of 0.4%, may be considered for topical application alone in the treatment of AOE, without any requirement for a combined treatment.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29283096      PMCID: PMC6354478          DOI: 10.5152/iao.2017.4213

Source DB:  PubMed          Journal:  J Int Adv Otol        ISSN: 1308-7649            Impact factor:   1.017


  14 in total

Review 1.  Thymoquinone: potential cure for inflammatory disorders and cancer.

Authors:  Chern Chiuh Woo; Alan Prem Kumar; Gautam Sethi; Kwong Huat Benny Tan
Journal:  Biochem Pharmacol       Date:  2011-10-10       Impact factor: 5.858

Review 2.  Immunomodulatory and therapeutic properties of the Nigella sativa L. seed.

Authors:  Mohamed Labib Salem
Journal:  Int Immunopharmacol       Date:  2005-07-01       Impact factor: 4.932

3.  Ameliorative effect of thymoquinone on ovalbumin-induced allergic conjunctivitis in Balb/c mice.

Authors:  Khizar Hayat; M B Raza Asim; Muhammad Nawaz; Miao Li; Lin Zhang; Naixue Sun
Journal:  Curr Eye Res       Date:  2011-05-23       Impact factor: 2.424

4.  External otitis caused by infection with Pseudomonas aeruginosa or Candida albicans cured by use of a topical group III steroid, without any antibiotics.

Authors:  Per Emgård; Sten Hellström; Stig Holm
Journal:  Acta Otolaryngol       Date:  2005-04       Impact factor: 1.494

5.  Microbiology of acute otitis externa.

Authors:  Peter S Roland; David W Stroman
Journal:  Laryngoscope       Date:  2002-07       Impact factor: 3.325

Review 6.  Interventions for acute otitis externa.

Authors:  Vivek Kaushik; Tass Malik; Shakeel R Saeed
Journal:  Cochrane Database Syst Rev       Date:  2010-01-20

7.  Comparison of efficacy and safety of ciprofloxacin otic solution 0.2% versus polymyxin B-neomycin-hydrocortisone in the treatment of acute diffuse otitis externa*.

Authors:  Margaret Drehobl; Juan Lorente Guerrero; Pilar Rivas Lacarte; Gary Goldstein; Francisco Sabater Mata; Stephen Luber
Journal:  Curr Med Res Opin       Date:  2008-12       Impact factor: 2.580

Review 8.  Acute otitis externa: an update.

Authors:  Paul Schaefer; Reginald F Baugh
Journal:  Am Fam Physician       Date:  2012-12-01       Impact factor: 3.292

9.  Clinical practice guideline: acute otitis externa.

Authors:  Richard M Rosenfeld; Lance Brown; C Ron Cannon; Rowena J Dolor; Theodore G Ganiats; Maureen Hannley; Phillip Kokemueller; S Michael Marcy; Peter S Roland; Richard N Shiffman; Sandra S Stinnett; David L Witsell
Journal:  Otolaryngol Head Neck Surg       Date:  2006-04       Impact factor: 5.591

10.  Treatment of acute otitis externa with ciprofloxacin otic 0.2% antibiotic ear solution.

Authors:  R Mösges; M Nematian-Samani; A Eichel
Journal:  Ther Clin Risk Manag       Date:  2011-07-27       Impact factor: 2.423

View more
  2 in total

1.  Effect of Nigella sativa and its bioactive compound on type 2 epithelial to mesenchymal transition: a systematic review.

Authors:  Abid Nordin; Haziq Kamal; Muhammad Dain Yazid; Aminuddin Saim; Ruszymah Idrus
Journal:  BMC Complement Altern Med       Date:  2019-10-30       Impact factor: 3.659

2.  The EDA-deficient mouse has Zymbal's gland hypoplasia and acute otitis externa.

Authors:  Jorge Del-Pozo; Denis J Headon; James D Glover; Ali Azar; Sonia Schuepbach-Mallepell; Mahmood F Bhutta; Jon Riddell; Scott Maxwell; Elspeth Milne; Pascal Schneider; Michael Cheeseman
Journal:  Dis Model Mech       Date:  2022-03-30       Impact factor: 5.758

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.